Intel Unveils Panther Lake AI Laptop Chips at CES 2025, Marking Major 18A Manufacturing Milestone 
Barclays Invests in Stablecoin Clearing Firm Ubyx to Advance Digital Money Strategy 
Mercedes-Benz to Launch Advanced Urban Self-Driving System in the U.S., Challenging Tesla FSD 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
BTIG Initiates Buy on SoftBank as AI and Robotics Strategy Gains Momentum 
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations 
China Reviews Meta’s $2 Billion AI Deal With Manus Amid Technology Control Concerns 
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid 
Embraer Boosts Aircraft Deliveries in Q4 2025, Signaling Strong Growth Into 2026 
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
Baidu’s AI Chip Unit Kunlunxin Prepares for Hong Kong IPO to Raise Up to $2 Billion 
Cathay Pacific Shares in Focus as Air China Plans Major Stake Reduction 
FDA Limits Regulation of Wearable Devices and Wellness Software, Boosting Health Tech Industry 
Dell Revives XPS Laptop Lineup With New XPS 14 and XPS 16 to Boost Premium PC Demand 
Discord Confidentially Files for U.S. IPO, Signaling Major Milestone 
Newmont Goldcorp Expects Lower Q1 2026 Gold Output After Western Australia Bushfire 
NEW YORK, March 15, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of NantHealth, Inc. ("NantHealth") (NASDAQ:NH) (1) pursuant and/or traceable to the Company’s initial public offering on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017. You are hereby notified that Levi & Korsinsky has commenced the securities class action lawsuit Shafik v. NantHealth, Inc., et al. (Case No. 2:17-cv-01940-DMG-SS) in the USDC for the Central District of California. To get more information go to:
http://www.zlk.com/pslra/nanthealth-inc
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose: (1) that Company founder Patrick Soon-Shiong had donated funds through nonprofit organizations to the University of Utah for the purpose of funneling those funds back into NantHealth; (2) that, as such, the Company and Soon-Shiong participated in the violation of federal tax laws—exposing the Company to possible civil and criminal liability; (3) that the Company improperly recorded orders received from the University of Utah as GPS Cancer test orders; and (4) that, as a result, the Company reported false and inflated GPS Cancer order figures for the third quarter of 2016.
If you suffered a loss in NantHealth you have until May 8, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
